PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

Objectives. To evaluate the use of prostate-specific antigen (PSA) velocity (PSAV) in assessing prostate cancer risk among men with PSA levels less than 4.0 ng/mL. Methods. The relative risk of, and cumulative probability of freedom from, prostate cancer by PSAV was evaluated in 89 male participants...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Urology (Ridgewood, N.J.) N.J.), 2002-06, Vol.59 (6), p.889-893
Hauptverfasser:	Fang, Junyong, Metter, E.Jeffrey, Landis, Patricia, Carter, H.Ballentine
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Case-Control Studies Humans Male Middle Aged Prospective Studies Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Regression Analysis Risk Assessment Sensitivity and Specificity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!